TCTR20170827002
Completed
Phase 4
The effect of selenium supplementation in moderate-to-severe thyroid eye disease patients : a randomized-placebo controlled trial
The Ratchadapiseksompotch Fund, Faculty of Medicine0 sites46 target enrollmentAugust 27, 2017
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Moderate-to-severe thyroid eye disease patients
- Sponsor
- The Ratchadapiseksompotch Fund, Faculty of Medicine
- Enrollment
- 46
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.The patients who have been categorized into moderate\-to\-severe thyroid eye disease group according to EUGOGO recommendation.
- •2\. Age above 18 years old
- •3\. The patients with normal thyroid hormone level (FT4, FT3\) for at least 6 months
- •4\. The patients who presented with thyroid eye symptoms of less than 18 months.
Exclusion Criteria
- •1\. The patients who have history of allergic reaction to selenium
- •2\. The patients who previously took or who are currently taking selenium supplement.
- •3\. The patients who are pregnant or breast\-feeding.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 3
effect of selenium in systemic lupus erythematosusIRCT20210717051914N2Ahvaz University of Medical Sciences56
Not yet recruiting
Phase 3
The effect of supplementation with organic selenium on sperm parameters, serum levels of androgens, sexual function, and quality of sexual life in infertile meIRCT20131009014957N11Tabriz University of Medical Sciences80
Completed
Phase 2
The effect of selenium on nephropathy complications of diabetic patientsnon-insulin-dependent diabetes mellitus with renal complicationsE11.2diabetic nephropathy.IRCT2015060622562N1Vice chancellor for research, Kashan University of Medical Sciences60
Recruiting
Phase 2
Evaluation of the effect of selenium on patients with thyroid cancer treated with radioactive iodineThyroid cancer.Neoplasm of uncertain behavior of thyroid glandD44.0IRCT20201129049534N6Esfahan University of Medical Sciences60
Completed
Phase 2
Investigation of the effect of Selenium in beta thalassemia majorthalassemia major.Beta thalassemiaD56.1IRCT20180603039959N3Ahvaz University of Medical Sciences42